Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Pacanowski

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 3, 2024
Leveraging in Vitro Models for Clinically Relevant Rare <i>CYP2D6</i> Variants in PharmacogenomicsSydney Stern, Paula L Hyland, Michael Pacanowski, et al.
Clinical Pharmacology and Therapeutics|August 24, 2023
A Multistakeholder Perspective on Advancing Individualized TherapeuticsMichael Pacanowski, Julia Vitarello, Insoo Hyun, et al.
Clinical and Translational Science|February 22, 2019
Use of Titration as a Therapeutic Individualization Strategy: An Analysis of Food and Drug Administration-Approved DrugsRobert N Schuck, Michael Pacanowski, Sarah Kim, et al.
Clinical and Translational Science|February 28, 2025
Evaluation of the Landscape of Pharmacodynamic Biomarkers in GM1 and GM2 GangliosidosisSydney Stern, Karryn Crisamore, Ruo-Jing Li, et al.
Clinical and Translational Science|August 25, 2019
Evolution of Next Generation Therapeutics: Past, Present, and Future of Precision MedicinesAnuradha Ramamoorthy, Jason H Karnes, Richard Finkel, et al.
Pharmacogenomics|April 9, 2025
Utilization of polygenic risk scores in drug development protocolsMichelle A Pressly, Robert Schuck, Padmaja Mummaneni, et al.
Nature Reviews. Drug Discovery|February 26, 2026
Dose-finding and optimization in drug development for rare diseasesRobert N Schuck, Ruo-Jing Li, Mia Williams, et al.
Biomarkers in Medicine|September 16, 2025
Trends in clinical studies evaluating neurofilament light chain as a biomarkerSydney Stern, Kristin Jamenis, Sreedharan Sabarinath, et al.
Journal of Clinical Pharmacology|June 26, 2025
The Evaluation of Interactions Between Multiple Intrinsic and Extrinsic Factors Reported in Labeling for FDA-Approved DrugsSamantha Lynn Bailey, Sydney Stern, Elyes Dahmane, et al.
Clinical Pharmacology and Therapeutics|September 8, 2021
Expanding Approved Patient Populations for Rare Disease Treatment Using In Vitro DataJames L Weaver, Wendy Wu, Paula L Hyland, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 3, 2024
Leveraging in Vitro Models for Clinically Relevant Rare <i>CYP2D6</i> Variants in PharmacogenomicsSydney Stern, Paula L Hyland, Michael Pacanowski, et al.
Clinical Pharmacology and Therapeutics|August 24, 2023
A Multistakeholder Perspective on Advancing Individualized TherapeuticsMichael Pacanowski, Julia Vitarello, Insoo Hyun, et al.
Clinical and Translational Science|February 22, 2019
Use of Titration as a Therapeutic Individualization Strategy: An Analysis of Food and Drug Administration-Approved DrugsRobert N Schuck, Michael Pacanowski, Sarah Kim, et al.
Clinical and Translational Science|February 28, 2025
Evaluation of the Landscape of Pharmacodynamic Biomarkers in GM1 and GM2 GangliosidosisSydney Stern, Karryn Crisamore, Ruo-Jing Li, et al.
Clinical and Translational Science|August 25, 2019
Evolution of Next Generation Therapeutics: Past, Present, and Future of Precision MedicinesAnuradha Ramamoorthy, Jason H Karnes, Richard Finkel, et al.
Pharmacogenomics|April 9, 2025
Utilization of polygenic risk scores in drug development protocolsMichelle A Pressly, Robert Schuck, Padmaja Mummaneni, et al.
Nature Reviews. Drug Discovery|February 26, 2026
Dose-finding and optimization in drug development for rare diseasesRobert N Schuck, Ruo-Jing Li, Mia Williams, et al.
Biomarkers in Medicine|September 16, 2025
Trends in clinical studies evaluating neurofilament light chain as a biomarkerSydney Stern, Kristin Jamenis, Sreedharan Sabarinath, et al.
Journal of Clinical Pharmacology|June 26, 2025
The Evaluation of Interactions Between Multiple Intrinsic and Extrinsic Factors Reported in Labeling for FDA-Approved DrugsSamantha Lynn Bailey, Sydney Stern, Elyes Dahmane, et al.
Clinical Pharmacology and Therapeutics|September 8, 2021
Expanding Approved Patient Populations for Rare Disease Treatment Using In Vitro DataJames L Weaver, Wendy Wu, Paula L Hyland, et al.
Pageof 5